Shutaishen: many projects under research of the company, including bdb-001 injection, are innovative biological products
Financial Associated Press, November 26 - shutaishen issued an announcement of abnormal fluctuations in stock trading. Many of the company's research projects, including bdb-001 injection, belong to innovative biological products. Innovative biomedicine has the characteristics of high technology, high risk and high added value. It has a long cycle and many links from development, clinical trial, application for approval to production, and is vulnerable to many factors such as technology, approval and policy.
This text is a result of machine translation.
Briefing Aug 01, 2022 03:11 PM
· Healthcare
Biomedical Lab Supplies Producer Acumen Bags 100 Mn of CNY in Series A Round
Briefing Jul 29, 2022 05:35 PM
· Automotive
ZhidaoAuto Signed CNY 3 Bn Contract with Sichuan Government in Autonomous Driving Project
In-depth
Briefing Jul 29, 2022 11:42 AM
· Technology
IC Design Company Yuntu Harvests Hundreds of Mns of CNY in Series A+
Aug 09, 2022 04:42 PM
Jun 27, 2022 05:00 PM
May 02, 2022 07:50 PM
Apr 18, 2022 09:14 PM
Briefing Jun 28, 2022 05:11 PM
· Automotive
Gaode started the "cooling action" by taking a taxi and gave high-temperature subsidies to encourage drivers to turn on more air conditioners
Briefing Jun 28, 2022 04:59 PM
· Automotive
Germany started the "cooling action" by taking a taxi and gave high-temperature subsidies to encourage drivers to turn on more air conditioners
Briefing Jun 28, 2022 04:29 PM
· Healthcare
Shuidi company has established a new pharmaceutical innovation division to further develop the pharmaceutical direction
See more
Read next
Insight
In-depth
Automotive
Envisioning Future Mobility in China: the Status and Prospect of DMS
Aug 18, 2022 11:19 AM
Insight
In-depth